Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000251476 | SCV000320637 | likely benign | Cardiovascular phenotype | 2015-12-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001701837 | SCV000516087 | likely benign | not provided | 2021-01-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625300 | SCV000744767 | likely benign | Arrhythmogenic right ventricular dysplasia 11 | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001184484 | SCV001350462 | likely benign | Cardiomyopathy | 2018-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000625300 | SCV001609282 | likely benign | Arrhythmogenic right ventricular dysplasia 11 | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000438129 | SCV001922141 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701837 | SCV001929785 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001701837 | SCV001954529 | likely benign | not provided | no assertion criteria provided | clinical testing |